15/03/2019 01:43:09

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Syneos Health, Inc. - SYNH

NEW YORK, March 14, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Syneos Health, Inc. (“Syneos” or the “Company”) (NASDAQ: SYNH).   Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980.

The investigation concerns whether Syneos and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here to join a class action]

On February 27, 2019, after market hours, Syneos announced that it was delaying the release of its Form 10-K for the year ended December 31, 2018, after the U.S. Securities and Exchange Commission notified the Company that it was investigating its revenue accounting policies and internal controls.  Syneos advised investors that its management and Audit Committee were each conducting a review of the Company’s internal controls and/or accounting policies, amongst other things. 

On this news, Syneos’s stock price fell $10.24 per share, or 19.69%, to close at $41.77 per share on February 28, 2019.

The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.

CONTACT: 

Robert S. Willoughby

Pomerantz LLP 

rswilloughby@pomlaw.com

Del

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
15 May
DANSKE
Meget interessant refleksion skrevet af Maui. Det kan vores medier godt lære lidt af. Det der kommer..
25
15 May
PNDORA
I gaar aftes sad jeg og kiggede lidt naermere paa guidance fra Pandora for FY2019, som de meldte ud ..
22
21 May
VELO
Så er der lidt at læse på. . Se bla.. Purpose: Tacrolimus extended release (TacER) (Envarsus XR®) ha..
19
17 May
VELO
Hej Alle,   Har siddet og kigget på regnskabet, for at finde ud af hvordan 2019 ender. Umiddelbart e..
18
20 May
PNDORA
Paa trods af et godkendt Q1 regnskab, er aktien faldet som en sten. Markedet er ligeglad med Pandora..
17
18 May
VWS
Ditlev.. Havde store ambitioner, og store armbevægelser .. Ikke alt gik godt.. Men finanskrisen kan..
17
15 May
DANSKE
Apropos skribent 6212.. Og Danske Bank..Ja så må man lade vedkommende at han/hun fik ret. Han anbefa..
16
20 May
DANSKE
Hører på Radio247 at Jyske Bank er indblandet i momssvindel via et par kunder. Penge ud og ind på en..
15
18 May
ZEAL
Nedenfor er det samlet udskift af Q1 telefonkonferencen for Zealand Pharma.    Jeg har først trukket..
15
18 May
AMBU-B
Cook Medical er en førende amerikansk medicovirksomhed med en omsætning på ca. 2 mia. usd og aktivit..
14

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Motif Bio to Present Iclaprim Data at ASM Microbe 2019
2
Start of Day Message
3
American Shipping Company ASA - Key information relating to the cash dividend to be paid by AMSC
4
F-Secure Corporation - Managers' Transactions
5
HP and Smile Direct Club Collaborate on Largest Multi Jet Fusion 3D Production Factory in the U.S.

Latest news


Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
22 May 2019 02:36:57
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190514.2 - EUROWEB2 - 2019-05-22 03:36:57 - 2019-05-22 02:36:57 - 1000 - Website: OKAY